 |
Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases.
Mathew, P., Wen, S., Morita, S., Thall, P.F.
|
J Interferon Cytokine Res. |
2011 |
|
Placental Growth Factor and Soluble c-Kit Receptor Dynamics Characterize the Cytokine Signature of Imatinib in Prostate Cancer and Bone Metastases.
Mathew, P., Wen, S., Morita, S., Thall, P.F.
|
J Interferon Cytokine Res. |
2011 |
|
Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors.
Fujisaka, Y., Yamada, Y., Yamamoto, N., Shimizu, T., Fujiwara, Y., Yamada, K., Tamura, T., Watanabe, H., Sun, Y.N., Bass, M.B., Seki, M.
|
Cancer Chemother Pharmacol. |
2010 |
|
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse.
Jain S, Cohen J, Ward MM, Kornhauser N, Chuang E, Cigler T, Moore A, Donovan D, Lam C, Cobham MV, Schneider S, Hurtado Rúa SM, Benkert S, Mathijsen Greenwood C, Zelkowitz R, Warren JD, Lane ME, Mittal V, Rafii S, Vahdat LT.
|
Ann Oncol |
2013 |
|
|
|
|
 |
| Price |
Please call for price |
| Size |
1 plate |
| Catalog No. |
K151BPC-1 |
| Availability |
|
|
Home
Products
K151BPC-1
